Reporting owner · Q3 2026 · CIK 1817199

Ring Christine: insider trades.

Ring Christine reported 12 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($881K), across 1 company.

Transactions
12
Purchases (P)
0
Sales (S)
5
Companies
1
Name as filed
Ring Christine

Companies

CompanyRelationshipTransactions
Nurix Therapeutics, Inc. (NRIX)Officer · Chief Legal Officer12

Transactions

12 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-02Nurix Therapeutics, Inc.M5,787$8.7214,897Form 4
2026-09-02Nurix Therapeutics, Inc.S400$26.649,110Form 4
2026-09-02Nurix Therapeutics, Inc.S5,387$25.699,510Form 4
2026-08-03Nurix Therapeutics, Inc.S16,589$23.059,110Form 4
2026-08-03Nurix Therapeutics, Inc.M5,787$8.7225,699Form 4
2026-07-30Nurix Therapeutics, Inc.M3,572$023,759Form 4
2026-07-30Nurix Therapeutics, Inc.M2,858$020,187Form 4
2026-07-30Nurix Therapeutics, Inc.M3,750$017,329Form 4
2026-07-30Nurix Therapeutics, Inc.S3,847$23.3819,912Form 4
2026-07-02Nurix Therapeutics, Inc.S11,008$23.5613,579Form 4
2026-07-02Nurix Therapeutics, Inc.M5,787$8.7224,587Form 4
2026-07-02Nurix Therapeutics, Inc.M5,221$1.8618,800Form 4

Questions

What stock did Ring Christine buy or sell?

Ring Christine reported 12 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 5 sales ($881K), across 1 company.

Is Ring Christine the same person as other filers with this name?

This page covers SEC CIK 1817199 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/ring-christine-1817199.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.